High expression levels of ZAP-70 and CD38 are associated with poor outcomes in CLL patients, and CD38 positivity is frequently related to more severe clinical manifestations [39], and to simultaneous CD49d and CD11c (other two adhesion molecules) positivity. This evidence concerns the gene ITGA4 and B-cell chronic lymphocytic leukemia.